This study highlights that lncRNA MEG3 may serve as a potential marker for mitigating hyperglycemia-induced neurotoxicity and associated pathologies, reflecting the microenvironment observed in Alzheimer’s disease. This evidence concerns the gene MEG3 and early-onset autosomal dominant Alzheimer disease.